Q-TWiST analysis comparing ipilimumab/dacarbazine vs placebo/dacarbazine for patients with stage III/IV melanoma

BACKGROUND: Study CA184024 was a multinational, randomised, double-blind, phase 3 study comparing ipilimumab/dacarbazine (DTIC) vs placebo/DTIC in patients with untreated stage III/IV melanoma, which showed that ipilimumab significantly improves survival in patients with metastatic melanoma. The obj...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Sherrill, B, Wang, J, Kotapati, S, Chin, K
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group 2013
Témata:
Clinical Study
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3708560/
https://ncbi.nlm.nih.gov/pubmed/23787916
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2013.298
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky